

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a ...
Q2 2026
Aug 6, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 26, 2026
Q4 2025
Mar 26, 2026
Q3 2025
Nov 10, 2025